WAVE Life Sciences Ltd.
WVE
$13.02
-$0.33-2.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 42.73M | 109.23M | 93.95M | 104.94M | 108.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 42.73M | 109.23M | 93.95M | 104.94M | 108.30M |
| Cost of Revenue | 182.78M | 174.61M | 169.93M | 166.86M | 159.68M |
| Gross Profit | -140.05M | -65.38M | -75.99M | -61.92M | -51.38M |
| SG&A Expenses | 75.33M | 70.57M | 67.52M | 63.83M | 59.02M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 258.11M | 245.18M | 237.46M | 230.69M | 218.71M |
| Operating Income | -215.38M | -135.95M | -143.51M | -125.75M | -110.40M |
| Income Before Tax | -204.38M | -121.95M | -129.87M | -112.33M | -97.01M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -204.38 | -121.95 | -129.87 | -112.33 | -97.01 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -204.38M | -121.95M | -129.87M | -112.33M | -97.01M |
| EBIT | -215.38M | -135.95M | -143.51M | -125.75M | -110.40M |
| EBITDA | -211.94M | -132.45M | -139.92M | -122.02M | -106.51M |
| EPS Basic | -1.21 | -0.74 | -0.88 | -0.83 | -0.78 |
| Normalized Basic EPS | -0.76 | -0.46 | -0.55 | -0.52 | -0.49 |
| EPS Diluted | -1.21 | -0.75 | -0.89 | -0.84 | -0.79 |
| Normalized Diluted EPS | -0.76 | -0.47 | -0.56 | -0.52 | -0.50 |
| Average Basic Shares Outstanding | 674.53M | 655.74M | 620.57M | 586.11M | 552.85M |
| Average Diluted Shares Outstanding | 674.53M | 666.54M | 631.37M | 596.91M | 563.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |